{
  "id": "5c0117fd133db5eb7800002a",
  "type": "factoid",
  "question": "When did delafloxacin receive its first approval in the USA for acute bacterial skin and skin structure infections?",
  "ideal_answer": "Delafoxacin received approval in the USA for the treatment of acute bacterial skin and skin structure infections in 2017.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/28748399"
  ],
  "snippets": [
    {
      "text": "The drug is being investigated or considered as a treatment for various bacterial infections and in June 2017 received approval in the USA for the treatment of acute bacterial skin and skin structure infections. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28748399",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "2017"
}